Advertisement

Index by author

November 01, 1982; Volume 10,Issue 6

  1. Lehman, J P

    1. Iminocyclophosphamide as a chemically reactive metabolite of cyclophosphamide.
      C Fenselau, J P Lehman, A Myles, J Brandt, G S Yost, O M Friedman and O M Colvin
      Drug Metabolism and Disposition November 1982, 10 (6) 636-640;

  2. Lertratanangkoon, K

    1. Urinary bivalent sulfur metabolites of phenanthrene excreted by the rat and guinea pig.
      K Lertratanangkoon, M G Horning, B S Middleditch, W S Tsang and G W Griffin
      Drug Metabolism and Disposition November 1982, 10 (6) 614-623;

  3. Levin, W

    1. Effects of three recombinant human leukocyte interferons on drug metabolism in mice.
      A Parkinson, J Lasker, M J Kramer, M T Huang, P E Thomas, D E Ryan, L M Reik, R L Norman, W Levin and A H Conney
      Drug Metabolism and Disposition November 1982, 10 (6) 579-585;

  4. Lindeke, B

    1. Cytochrome P-455-nm complex formation in the metabolism of phenylalkylamines. VI. Structure--activity relationships in metabolic intermediary complex formation with a series of alpha-substituted 2-phenylethylamines and corresponding N-hydroxylamines.
      B Lindeke, U Paulsen-Sörman, G Hallström, A H Khuthier, A K Cho and R C Kammerer
      Drug Metabolism and Disposition November 1982, 10 (6) 700-705;

  5. Liu, A L

    1. Species-related differences in the stereoselective glucuronidation of oxazepam.
      S F Sisenwine, C O Tio, F V Hadley, A L Liu, H B Kimmel and H W Ruelius
      Drug Metabolism and Disposition November 1982, 10 (6) 605-608;

  6. Madelmont, J C

    1. Main metabolites of 1-(2-chloroethyl)-3-[1'-(5'-p-nitrobenzoyl-2',3'-isopropylidene)-alpha, beta-D-ribofuranosyl]-1-nitrosourea and 1-(2-chloroethyl)-3-(2',3', 4'-tri-O-acetyl-alpha, beta-D-ribopyranosyl)-1-nitrosourea in rats.
      J C Madelmont, M F Moreau, D Godeneche, J Duprat, R Plagne and G Meyniel
      Drug Metabolism and Disposition November 1982, 10 (6) 662-666;

  7. Maguire, J H

    1. 5-ethyl-5-phenylhydantoin N-glucuronide, the major urinary metabolite of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
      J H Maguire, T C Butler and K H Dudley
      Drug Metabolism and Disposition November 1982, 10 (6) 595-598;

  8. Martin, B R

    1. Disposition of phencyclidine in mice after smoke exposure.
      A S Freeman and B R Martin
      Drug Metabolism and Disposition November 1982, 10 (6) 680-684;
    2. In vitro metabolism of 1-phenyl-1-cyclohexene, a pyrolysis product of phencyclidine.
      B R Martin, B B Bailey, H Awaya, E L May and N Narasimhachari
      Drug Metabolism and Disposition November 1982, 10 (6) 685-689;

  9. May, E L

    1. In vitro metabolism of 1-phenyl-1-cyclohexene, a pyrolysis product of phencyclidine.
      B R Martin, B B Bailey, H Awaya, E L May and N Narasimhachari
      Drug Metabolism and Disposition November 1982, 10 (6) 685-689;

  10. Meyniel, G

    1. Main metabolites of 1-(2-chloroethyl)-3-[1'-(5'-p-nitrobenzoyl-2',3'-isopropylidene)-alpha, beta-D-ribofuranosyl]-1-nitrosourea and 1-(2-chloroethyl)-3-(2',3', 4'-tri-O-acetyl-alpha, beta-D-ribopyranosyl)-1-nitrosourea in rats.
      J C Madelmont, M F Moreau, D Godeneche, J Duprat, R Plagne and G Meyniel
      Drug Metabolism and Disposition November 1982, 10 (6) 662-666;
« Previous (Pages : 3 4 5 6 7 8 9 10 11 12 ... 12) Next »
Back to top

In this issue

Advertisement